Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide. Elpiscience has a robust pipeline of globally innovative cancer immunotherapies covering a wide range of oncology targets. Through internal R&D expertise and partnerships with global biopharmaceutical companies, Elpiscience endeavors to advance at least one innovative program into clinic each year.
Our Vision

Innovate transformative medicines that improve cancer patients' lives worldwide.

  • Passion
    Make everything possible!
  • Leadership
    Let you win!
  • pleasure
    Help you achieve your career!
Our Mission

To discover and develop novel high-quality cancer therapeutics efficiently.

Play the video
Core Values
Elpiscience has raised approximately $260 million and is supported by top-tier healthcare investors.